Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Capecitabine and Docetaxel in the Treatment of Advanced and Recurrent Cervical Cancer

NCT00257348 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT00257348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Capecitabine and Docetaxel in the Treatment of Advanced and Recurrent Cervical Cancer
Lead sponsor
University of California, Irvine
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
July 31, 2007
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer